Wucherpfennig, Kai W.
Brigham and Women's Hospital · Harvard University · Dana-Farber Cancer Institute · Dana-Farber/Harvard Cancer Center · Dana-Farber Brigham Cancer Center
15 papers on CoChatORCID 0000-0002-1829-302X
Most cited papers
- Verified
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., et al. (2018) · Nature Medicine
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 5,179
- Verified
An immunogenic personal neoantigen vaccine for patients with melanoma
Ott, P. A., Hu, Z., Keskin, D. B., Shukla, S. A., Sun, J., Bozym, D. J., Zhang, W., Luoma, A., Giobbie-Hurder, A., Peter, L., et al. (2017) · Nature
Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers
Cited by 2,936
- Verified
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Keskin, D. B., Anandappa, A. J., Sun, J., Tirosh, I., Mathewson, N. D., Li, S., Oliveira, G., Giobbie-Hurder, A., Felt, K., Gjini, E., et al. (2019) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 1,432
- Verified
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
Jerby-Arnon, L., Shah, P., Cuoco, M. S., Rodman, C., Su, M.-J., Melms, J. C., Leeson, R., Kanodia, A., Mei, S., Lin, J.-R., et al. (2018) · Cell
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 1,429
- Verified
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
Formenti, S. C., Rudqvist, N.-P., Golden, E., Cooper, B., Wennerberg, E., Lhuillier, C., Vanpouille-Box, C., Friedman, K., Ferrari de Andrade, L., Wucherpfennig, K. W., et al. (2018) · Nature Medicine
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 928
- Verified
A major chromatin regulator determines resistance of tumor cells to T cell–mediated killing
Pan, D., Kobayashi, A., Jiang, P., Ferrari de Andrade, L., Tay, R. E., Luoma, A. M., Tsoucas, D., Qiu, X., Lim, K., Rao, P., et al. (2018) · Science
Cancer Immunotherapy and BiomarkersChromatin Remodeling and Cancer
Cited by 852
- Verified
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Alspach, E., Lussier, D. M., Miceli, A. P., Kizhvatov, I., DuPage, M., Luoma, A. M., Meng, W., Lichti, C. F., Esaulova, E., Vomund, A. N., et al. (2019) · Nature
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 846
- Verified
Molecular Pathways of Colon Inflammation Induced by Cancer Immunotherapy
Luoma, A. M., Suo, S., Williams, H. L., Sharova, T., Sullivan, K., Manos, M., Bowling, P., Hodi, F. S., Rahma, O., Sullivan, R. J., et al. (2020) · Cell
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 484
- Verified
Th17 Cells Induce Ectopic Lymphoid Follicles in Central Nervous System Tissue Inflammation
Peters, A., Pitcher, L. A., Sullivan, J. M., Mitsdoerffer, M., Acton, S. E., Franz, B., Wucherpfennig, K., Turley, S., Carroll, M. C., Sobel, R. A., et al. (2011) · Immunity
T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis
Cited by 480
- Verified
T cell‐targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
Schmid, D., Park, C. G., Hartl, C. A., Subedi, N., Cartwright, A. N., Puerto, R. B., Zheng, Y., Maiarana, J., Freeman, G. J., Wucherpfennig, K. W., et al. (2017) · Nature Communications
Nanoparticle-Based Drug DeliveryCancer Immunotherapy and Biomarkers
Cited by 449
- Verified
Understanding and treating the inflammatory adverse events of cancer immunotherapy
Dougan, M., Luoma, A. M., Dougan, S. K., & Wucherpfennig, K. W. (2021) · Cell
Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses
Cited by 319
- Verified
Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion
Frangieh, C. J., Melms, J. C., Thakore, P. I., Geiger-Schuller, K. R., Ho, P., Luoma, A. M., Cleary, B., Jerby-Arnon, L., Malu, S., Cuoco, M. S., et al. (2021) · Nature Genetics
Cancer Immunotherapy and BiomarkersSingle-cell and spatial transcriptomics
Cited by 276
- Verified
In vivo discovery of immunotherapy targets in the tumour microenvironment
Zhou, P., Shaffer, D. R., Alvarez Arias, D. A., Nakazaki, Y., Pos, W., Torres, A. J., Cremasco, V., Dougan, S. K., Cowley, G. S., Elpek, K., et al. (2014) · Nature
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 237
- Verified
Impaired thymic tolerance to α-myosin directs autoimmunity to the heart in mice and humans
Lv, H., Havari, E., Pinto, S., Gottumukkala, R. V. S. R. K., Cornivelli, L., Raddassi, K., Matsui, T., Rosenzweig, A., Bronson, R. T., Smith, R., et al. (2011) · Journal of Clinical Investigation
Viral Infections and Immunology ResearchT-cell and B-cell Immunology
Cited by 228
- Verified
A Spontaneous Model for Autoimmune Myocarditis Using the Human MHC Molecule HLA-DQ8
Taylor, J. A., Havari, E., McInerney, M. F., Bronson, R., Wucherpfennig, K. W., & Lipes, M. A. (2004) · The Journal of Immunology
Viral Infections and Immunology ResearchDiabetes and associated disorders
Cited by 63
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free